High expression of FDX1 promotes susceptibility to cuproptosis in HCC cells, enhances the infiltration of NK cells, Th1 cells, and macrophages, and increases sensitivity to oxaliplatin (163, 164). Here, FDX1 is linked to hepatocellular carcinoma.